ETANERCEPT WITHDRAWAL IN JIA
Juvenile Idiopathic Arthritis (JIA) is the most common rheumatic disease in children. The use of biologic therapy has improved prognosis and quality of life for these patients. Remission is more easily achieved and pediatric rheumatologists started to question if, when and how this expensive and pot...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Amaltea Medical Publishing House
2017-06-01
|
| Series: | Romanian Journal of Rheumatology |
| Subjects: | |
| Online Access: | https://rjr.com.ro/articles/2017.2/RJR_2017_2_Art-02.pdf |